Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.54 -0.30 (-1.21%)
Official Closing Price Updated: 7:00 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,368,557
Open 24.78
Bid (Size) 24.51 (1)
Ask (Size) 24.54 (1)
Prev. Close 24.84
Today's Range 24.46 - 24.95
52wk Range 20.91 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 7.01%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased
Jefferies thinks big pharma companies are "still on the hunt" for deals. 
Via Stocktwits
Exposures Product Safety
What's going on in today's session: S&P500 most active stocks
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill

Performance

YTD
-7.8%
-7.8%
1 Month
+8.6%
+8.6%
3 Month
-5.8%
-5.8%
6 Month
-2.8%
-2.8%
1 Year
-10.9%
-10.9%

More News

Read More
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
Via Benzinga
Exposures Product Safety
3 Healthcare Stocks with Questionable Fundamentals
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.’s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
From Berger Montague
Via GlobeNewswire
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.
Via Chartmill
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment
Via Stocktwits
Exposures COVID-19
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%
Via The Motley Fool
RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Report
Via Benzinga
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Via The Motley Fool
Topics Economy
Exposures Economy
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia
Via Investor's Business Daily
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Weight Loss Drug Stocks That Are Screaming Buys in June
Via The Motley Fool
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
From FN Media Group LLC
Via GlobeNewswire
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading
Via Benzinga
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?
Via Stocktwits
Topics Government
Exposures COVID-19 Political
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
Via Investor's Business Daily
Topics Government
Exposures COVID-19 Political
Metsera Stock Climbs On Positive Results From Early Stage Trial For Investigational Weight-Loss Drug: Retail Chatter Explodes
Via Stocktwits
Topics Government
Exposures Political
These S&P500 stocks are the most active in today's session
Via Chartmill
Pfizer CEO Reportedly Says Company Made No Drug Price Pledges In Meeting With Trump Administration: Retail Sentiment Improves
Via Stocktwits
Topics Artificial Intelligence Government
Exposures Artificial Intelligence COVID-19 Political
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Should You Buy Pfizer Stock Right Now?
Via The Motley Fool
Exposures COVID-19
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval
Via Benzinga
Exposures Product Safety
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts
Via Benzinga
Exposures COVID-19

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.54
When was Pfizer last traded?
The last trade of Pfizer was at 06/13/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 137.59B
How many shares of Pfizer are outstanding?
Pfizer has 138B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.